Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04919811
Title Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC (TRUST-II)
Acronym TRUST-II
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AnHeart Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | FRA | ESP | CAN

Additional content available in CKB BOOST